Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
996,000
-3,000 (-0.30%)
Last updated: Jun 27, 2025

Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 71.46 trillion as of June 27, 2025. Its market cap has increased by 38.10% in one year.

Market Cap
71.46T
Enterprise Value
71.59T
Revenue
4.90T
Ranking
n/a
PE Ratio
55.85
Stock Price
996,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 71.46T, an increase of 650.01%. That is a compound annual growth rate of 26.29%.

History

DateMarket Cap% Change
Jun 27, 202570.89T4.95%
Dec 30, 202467.54T24.87%
Dec 28, 202354.09T-7.43%
Dec 29, 202258.43T-2.20%
Dec 30, 202159.75T9.32%
Dec 30, 202054.65T90.76%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Celltrion 35.49T
ALTEOGEN 20.84T
Yuhan 7,589.05B
SK Biopharmaceuticals 7,236.14B
HLB Co., Ltd. 6,512.41B
PharmaResearch 4,992.23B
Peptron 4,741.01B
SK bioscience 3,973.32B
Market Cap Rankings